Navigation Links
Danaher Reports Record Fourth Quarter 2012 Results

ILITIES AND STOCKHOLDERS' EQUITYCurrent Liabilities:Notes payable and current portion of long-term debt



98.4Trade accounts payable

1,546.31,422.4Accrued expenses and other liabilities

2,604.32,651.2Total current liabilities

4,206.14,172.0Other long-term liabilities

4,363.43,598.9Long-term debt

5,287.65,206.8Stockholders' Equity:Common stock - $0.01 par value, 2.0 billion shares authorized; 774.6 and 761.1 issued;
87.5 and 687.7 outstanding, respectively

7.77.6Additional paid-in capital

3,688.13,877.2Retained earnings

15,379.913,056.9Accumulated other comprehensive income (loss)

(59.2)(36.9)Total Danaher stockholders' equity

19,016.516,904.8Non-controlling interests

67.467.0Total stockholders' equity

19,083.916,971.8Total liabilities and stockholders' equity



29,949.5This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information. 

($ in millions)Year Ended December 3120122011Cash flows from operating activities:Net earnings



2,172.3Less earnings from discontinued operations, net of income taxes

92.9237.0Net earnings from continuing operations

2,299.31,935.3Non-cash items:Depreciation


342.0284.3Stock compensation expense

109.995.6Earnings from unconsolidated joint venture, net of cash dividends received

(25.4)(18.4)Change in deferred income taxes

184.9271.4Change in trade accounts receivable, net

(79.7)(135.3)Change in inventories

69.8162.0Change in trade accounts payable


SOURCE Danaher Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
2. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
3. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
4. Cepheid Reports Fourth Quarter And Full Year 2012 Results
5. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
6. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
8. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
9. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
10. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
11. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Post Your Comments:
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers ... board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ... per share. Concerned SLXP investors are encouraged to contact ... The investigation focuses upon the shareholder value ... Salix shareholders would receive only $158.00 per share in ...
(Date:2/27/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is ... Conference on March 10 in Miami Beach ... vice president and chief financial officer, and Susie ... a 25-minute question and answer session regarding the company ... Following a 5-minute break, a question and answer session ...
(Date:2/27/2015)... MISSISSAUGA, ON , Feb. 27, 2015 /CNW/ - Covalon ... advanced medical technologies company, today announced financial results for ... For the three months ended December 31, 2014, ... for the quarter was $229,820 or $0.02 per share.  ... Pedlar , said "I am very pleased with the ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... NEW YORK, Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: ... paper published in Nucleic,Acids Research by a group ... ability of furamidine to inhibit a key enzyme ... Furamidine is the active metabolite (DB75),of Immtech,s proprietary, ...
... Scheduled Start of Phase 3 Clinical Trial, BELTSVILLE, ... has reported a second quarter 2007 loss from continuing,operations ... to a loss from,continuing operations of $699,000, or 5 ... from discontinued operations in the second quarter,of 2007 was ...
Cached Medicine Technology:Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3Spherix Reports Second Quarter Earnings 2
(Date:2/28/2015)... In recent years Medical Marijuana has continuously been ... a way for them to expand their patient base without ... Since the FDA still lists Cannabis as a Schedule 1 ... physicians that can help guide them when recommending a ... in Santa Cruz, CA is a leader in the small, ...
(Date:2/28/2015)... AB (PRWEB) February 28, 2015 The ... is now a distributor of the machine. The Heart ... of their license, like a franchise model. The goal ... prevent and reverse heart disease. To buy External ... Fit Clinic can help individuals through this process and ...
(Date:2/28/2015)... NB (PRWEB) February 28, 2015 ... center software suite for Asterisk, are pleased to announce ... highly successful 5.7 and 5.8 versions of Q-Suite, this ... well as a number of new features to the ... Q2 2015. , Q-Suite 5.9 will add features to ...
(Date:2/28/2015)... 28, 2015 National Sales ... sales, marketing and supply chain management for consumer ... is bringing its award winning solutions for thinning-damaged ... products are specifically created to combat thinning-damaged hair. ... is committed to marrying science with nature to ...
(Date:2/28/2015)... 28, 2015 How would you ... , There are all kinds of different leaders, ... awareness of the advantages and applications of different ... launching a new product this spring called The ... the connection between personality type, leadership, and success. ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... be "alarmingly dismal" with over 180 million urban poor having ... an industry analysis. ,At least 300 additional urban ... annually to cater to the needs of 215 million urban ... of Commerce and Industry of India (ASSOCHAM). ,In ...
... of colorectal cancers getting missed out in patients undergoing ... a gastroenterologist// or a surgeon. This was disclosed by ... researchers. ,This study was conducted on 12,487 ... Ontario along with her team. According to this study, ...
... flu in their county. This was disclosed by Faizullah Kakar, ... H5N1 virus was found in the eastern province of Nangarhar. ... diagnosed as the case of malaria. The Nangarhar area has ... ,Culling of birds was initiated earlier this week ...
... risk of mercury in canned albacore tuna in women and ... tuna in women and children. This follows a recent report ... cans of albacore tuna tested contained mercury more than the ... of canned albacore tuna per week can be had by ...
... and intolerance to gluten.// ,Inflammatory ... inflammations in muscular tissue. Coeliac disease is ... ,Inflammatory myopathies are inflammatory infiltrates ... includes polymyositis, dermatomyositis, and inclusion-body myositis. Little ...
... the heart gets its distinguishing shape? Shape may be formed ... and shape, all of which react to// influences from the ... bulges later on to develop into cardiac chambers. ... journal PLoS Biology, Heidi Auman, Deborah Yelon, and colleagues found, ...
Cached Medicine News:Health News:Urban Poor in Dire Need of Proper Healthcare: Report 2Health News:Inflammatory Myopathy may Indicate Intolerance to Gluten 2
Donor Screen & Confirmation Kit...
... method for Dimension integrated chemistry systems ... in vitro diagnostic test intended to ... (TPSA) in human serum or plasma. ... in the detection of prostate cancer ...
... Wampole Laboratories offers a comprehensive line of ... serum and urine in convenient one-step stick ... 2 testing options. Clearview Easy HCG is ... convenient stick format. Clearview HCG II ...
The BioCheck hCG ELISA is intended for the quantitative determination of human chorionic gonadotropin (hCG) concentration in human serum. The assay is for use in the early diagnosis of pregnancy in a...
Medicine Products: